Kissei Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3240600001
JPY
4,765.00
4742.4 (20984.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
26,802.00
23,640.00
22,191.00
22,661.00
23,203.00
21,302.00
21,164.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
26,802.00
23,640.00
22,191.00
22,661.00
23,203.00
21,302.00
21,164.00
Raw Material Cost
14,498.00
12,032.00
11,111.00
11,714.00
11,483.00
10,785.00
10,283.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
7.00
7.00
6.00
6.00
6.00
5.00
4.00
Selling and Distribution Expenses
9,149.00
20,554.00
8,971.00
6,617.00
9,264.00
6,388.00
6,137.00
Other Expenses
-0.70
-0.70
-0.60
278.80
-0.60
450.00
258.20
Total Expenditure (Excl Depreciation)
23,647.00
32,586.00
20,082.00
21,125.00
20,747.00
21,678.00
19,006.00
Operating Profit (PBDIT) excl Other Income
3155
-8946
2109
1536
2456
-376
2158
Other Income
1,257.00
11,963.00
3,530.00
2,739.00
4,691.00
2,194.00
3,440.00
Operating Profit (PBDIT)
5,608.00
4,183.00
6,727.00
5,435.00
8,320.00
2,979.00
6,719.00
Interest
7.00
7.00
6.00
6.00
6.00
5.00
4.00
Exceptional Items
-211.00
654.00
116.00
-231.00
-2,727.00
-175.00
-70.00
Gross Profit (PBDT)
12,304.00
11,608.00
11,080.00
10,947.00
11,720.00
10,517.00
10,881.00
Depreciation
1,196.00
1,166.00
1,088.00
1,160.00
1,173.00
1,161.00
1,121.00
Profit Before Tax
4,197.00
3,663.00
5,747.00
4,036.00
4,415.00
1,638.00
5,521.00
Tax
916.00
305.00
1,227.00
915.00
813.00
490.00
1,416.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,230.00
3,266.00
4,519.00
3,121.00
3,590.00
1,144.00
4,106.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,230.00
3,266.00
4,519.00
3,121.00
3,590.00
1,144.00
4,106.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
51.00
92.00
1.00
0.00
12.00
3.00
-1.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,281.00
3,358.00
4,520.00
3,121.00
3,602.00
1,147.00
4,105.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,16,392.00
2,11,380.00
2,07,087.00
2,09,004.00
2,10,203.00
2,19,657.00
2,19,812.00
Earnings per share (EPS)
77.92
78.76
107.87
72.91
82.65
25.86
92.88
Diluted Earnings per share
77.92
78.76
107.87
72.91
82.65
25.86
92.88
Operating Profit Margin (Excl OI)
11.77%
-37.84%
9.5%
6.78%
10.58%
-1.77%
10.2%
Gross Profit Margin
20.12%
20.43%
30.8%
22.93%
24.08%
13.14%
31.38%
PAT Margin
12.05%
13.82%
20.36%
13.77%
15.47%
5.37%
19.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 15.51% vs 11.12% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -8.91% vs 33.65% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 19.90% vs 12.88% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 16.67% vs 50.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Kissei Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
26,802.00
13,284.00
13,518.00
101.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
26,802.00
13,284.00
13,518.00
101.76%
Raw Material Cost
14,498.00
4,339.00
10,159.00
234.13%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
7.00
116.00
-109.00
-93.97%
Selling and Distribution Expenses
9,149.00
8,441.00
708.00
8.39%
Other Expenses
-0.70
-11.60
10.90
93.97%
Total Expenditure (Excl Depreciation)
23,647.00
12,780.00
10,867.00
85.03%
Operating Profit (PBDIT) excl Other Income
3,155.00
504.00
2,651.00
525.99%
Other Income
1,257.00
-167.00
1,424.00
852.69%
Operating Profit (PBDIT)
5,608.00
1,201.00
4,407.00
366.94%
Interest
7.00
116.00
-109.00
-93.97%
Exceptional Items
-211.00
-215.00
4.00
1.86%
Gross Profit (PBDT)
12,304.00
8,945.00
3,359.00
37.55%
Depreciation
1,196.00
864.00
332.00
38.43%
Profit Before Tax
4,197.00
8.00
4,189.00
52,362.50%
Tax
916.00
221.00
695.00
314.48%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,230.00
-424.00
3,654.00
861.79%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,230.00
-424.00
3,654.00
861.79%
Share in Profit of Associates
0
0
0.00
Minority Interest
51.00
211.00
-160.00
-75.83%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,281.00
-213.00
3,494.00
1,640.38%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,16,392.00
30,957.00
1,85,435.00
599.01%
Earnings per share (EPS)
77.92
-3.11
81.03
2,605.47%
Diluted Earnings per share
77.92
-3.11
81.03
2,605.47%
Operating Profit Margin (Excl OI)
11.77%
3.79%
0.00
7.98%
Gross Profit Margin
20.12%
6.56%
0.00
13.56%
PAT Margin
12.05%
-3.19%
0.00
15.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,680.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 13.38% vs 6.53% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 15.51% vs 11.12% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 328.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.29% vs -25.71% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -8.91% vs 33.65% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 435.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 155.93% vs -343.35% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 19.90% vs 12.88% in Dec 2024

Quarterly - Interest
Interest 0.70 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 16.67% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 16.67% vs 50.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.77%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024